Pharma Journalist -

Biognosys announced that it has secured USD 5m funding from new and existing investors in an extended series C round. Biognosys’ contract research services and tools are successfully…
Read More...

Lannett Company announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Cyproheptadine Hydrochloride…
Read More...

Following the recent launch by the publishers of the British National Formulary (BNF) and British National Formulary for children (BNFC) of a new, faster, easier to use and access app,…
Read More...

Viamet Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to VT-1598, a novel oral agent for the treatment of…
Read More...

In a new collaboration, ShangPharma Innovation, Inc. (SPII) is providing funding and other support to scientists at UC San Francisco (UCSF) to accelerate the development of promising…
Read More...

Allena Pharmaceuticals, Inc., a specialty biopharmaceutical company dedicated to bringing first in class, specific, non-absorbed, oral protein therapeutics to patients with serious…
Read More...

Sanofi announced it will acquire Protein Sciences, a privately held vaccines biotechnology company based in Meriden, Connecticut in the United States. Under the terms of the agreement,…
Read More...

BioDelivery Sciences International, Inc., a specialty pharmaceutical company with a focus in pain management and addiction medicine, and Purdue Pharma (Canada) announce that they have…
Read More...

Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has signed a licensing agreement and a…
Read More...

CURE Pharmaceutical, a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company and Therapix Biosciences, a specialty clinical-stage…
Read More...